Plasminogen Activator Inhibitor-1 and Vitamin D Association in the Overweight and Obese Pediatric Population

Nutrients. 2023 Aug 25;15(17):3717. doi: 10.3390/nu15173717.

Abstract

Background: Childhood overweight and obesity have been described by the World Health Organization as noncommunicable diseases and among the greatest public health threats since they have reached epidemic proportions. A child with obesity risks becoming an adult with obesity and developing metabolic and hemostatic disorders which are the basis for the development of coronary heart diseases. Recently, a number of clinical reports have demonstrated that both an increase in plasminogen activator inhibitor-1 (PAI-1) and a deficiency in 25OH-vitamin D3 (VD) are associated with an increase in thrombotic episodes.

Methods: PAI-1 and VD levels were measured in 259 clinically overweight and obese children aged between 2 and 18 years enrolled in the Nutritional Education Program of the Bambino Gesù Children's Hospital and Research Institute of Rome (Italy) and 80 normal-weight subjects.

Results: We observed increased HOMA-IR, PAI-1, and other inflammation indices associated with decreased VD levels when compared to normal-weight children.

Conclusions: Our results demonstrated that overweight and obesity are correlated with higher levels of the inflammation index. Moreover, our patients show high PAI-1 and low VD levels, confirming the high thrombotic risk in our pediatric population.

Keywords: BMI; HOMA-IR; PAI-1; children; insulin resistance; vitamin D.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Cholecalciferol
  • Humans
  • Inflammation
  • Overweight / complications
  • Pediatric Obesity* / complications
  • Plasminogen Activator Inhibitor 1
  • Vitamin D*
  • Vitamins

Substances

  • Vitamin D
  • Plasminogen Activator Inhibitor 1
  • Vitamins
  • Cholecalciferol